Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.
D000818:Animals; D001921:Brain / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D007490:Iproniazid / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D008995:Monoamine Oxidase / Q000378:metabolism*; D009206:Myocardium / Q000032:analysis / Q000378:metabolism; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D014316:Tritium; D014443:Tyrosine / Q000032:analysis
D002395:Catecholamines; D008781:Methyltyrosines; D014316:Tritium; D014443:Tyrosine; D012110:Reserpine; D010293:Pargyline; D007490:Iproniazid; D008995:Monoamine Oxidase; D004298:Dopamine; D009638:Norepinephrine